Investors & media
Financial data
Find the latest press releases, financial information, and performance updates.
Transforming rare disease care
We are a global specialty biopharmaceutical company expanding possibilities for people with rare diseases. With 50 years of experience in applying our scientific expertise and unique technologies to research, we continue to develop next-generation treatments and expand our global footprint to transform the lives of patients worldwide.
Newsroom
2025.09.12
JCR Pharmaceuticals celebrates its 50th anniversary of advancing science and changing lives
2025.09.08
JCR Pharmaceuticals sponsors and participates in relay for life of Ashiya
2025.09.08
JCR Pharmaceuticals presents long-term clinical data on pabinafusp alfa for the treatment of mucopolysaccharidosis type II (MPS II) at ICIEM 2025
2025.09.04
Notice of organizational and personnel changes
2025.09.01
Notice of personnel change
Performance data
JCR Pharmaceuticals (4552.T)
Tokyo Currency in JPY
632.00
+2.00
(+0.32%)
Last updated 09/17/2025 at TSE market close
Quarterly results
Driven by science and compassion, we tackle some of the most complex challenges in rare disease. Every solution we develop is grounded in insight into the genetic and biological foundations of the conditions we aim to treat.
Contact us
Investors & media